Skip to content

Outset Medical, Inc. OM Additional Paid-In Capital

Additional Paid-In Capital at other companies

Haemonetics logo
HaemoneticsHAE
$554.14M+5.9%
Teladoc Health logo
Teladoc HealthTDOC
$17.87B+0.4%
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
$1.26B+2.1%
ICU Medical logo
ICU MedicalICUI
$1.47B+3.5%
Baxter International logo
Baxter InternationalBAX
DaVita logo
DaVitaDVA

Other financials

Income statement

See full
Revenue$27.9M-6.3%
Gross profit$12.1M+9.3%
Operating income-$16.9M-3.2%
Net income-$19.0M+26.4%
EPS (diluted)-$1.03+71.9%

Balance sheet

See full
Cash & equivalents$30.6M-59.7%
Total debt$101.6M+3.5%
Total equity$111.7M-34.3%
Total assets$249.5M-17.2%

Cash flow

See full
Operating cash flow-$12.8M+50.0%
CapEx$65.0K-47.2%
Free cash flow-$12.9M+49.9%

Valuation

See full
Market cap$80.08M-75.5%
Enterprise value$151.13M-61.9%
P/S0.7×-2.1×

Profitability

See full
Gross margin40.6%+4.7pp
Operating margin-57.2%-12.9pp
Net margin-63.7%-16.7pp
FCF margin-29.1%-11.5pp

Returns & leverage

See full
Return on equity-53.2%-14.8pp
Debt / equity0.9×+0.3×
Current ratio6.3×-2.1×

Where this comes from

Reported directly by Outset Medical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: Outset Medical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Outset Medical, Inc.'s additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Outset Medical, Inc.'s additional paid-in capital?
Outset Medical, Inc. (OM) reported additional paid-in capital of $1.3B in Q1 2026.
How has Outset Medical, Inc.'s additional paid-in capital changed year-over-year?
Outset Medical, Inc.'s additional paid-in capital increased by 1.6% year-over-year, from $1.28B to $1.3B.
What is the long-term trend for Outset Medical, Inc.'s additional paid-in capital?
Over 5 years (2020 to 2025), Outset Medical, Inc.'s additional paid-in capital has grown at a 9.6% compound annual growth rate (CAGR), from $822.62M to $1.3B.
What does additional paid-in capital mean?
This represents the excess amount paid by investors for common shares over their par value. It is a key component of shareholders' equity that captures the capital raised through equity offerings beyond the nominal value of the stock. It reflects the historical market premium at which the company has issued its shares.